Prevention of Cardiac Allograft Vasculopathy Using Rituximab (Rituxan) Therapy in Cardiac Transplantation
Clinical trial NCT01278745 · TERMINATED
Trial details
- NCT number
- NCT01278745
- Sponsor
- National Institute of Allergy and Infectious Diseases (NIAID)
- Status
- TERMINATED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2011-09-01
- Primary completion
- 2015-10-01
- Enrollment
- 362
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.